AI assistant
Sending…
Roivant Sciences Ltd. — Director's Dealing 2025
Aug 2, 2025
30587_dirs_2025-08-01_ce1218cd-79e5-4182-9246-070c67c1303c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-07-30
Reporting Person: Venker Eric (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-30 | Common Shares | A | 198413 | — | Acquired | 1660636 | Direct |
Footnotes
F1: Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of May 20, 2025, which service-vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.
More from Roivant Sciences Ltd.
Regulatory Filings
2026
May 20
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 18